Covered recipient · General Payments record
MARIA-JOSEFINA S RIVERA
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2018–2024
$6,031.87
- Reported across 348 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $538.06 | 30 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Lilly USA, LLC | $159.16 | 7 |
| ABBVIE INC. | $156.69 | 11 |
| Mylan Specialty L.P. | $92.57 | 4 |
| Acerta Pharma LLC | $61.05 | 4 |
| GlaxoSmithKline, LLC. | $19.25 | 1 |
| Vanda Pharmaceuticals Inc. | $17.17 | 1 |
| Insulet Corporation | $17.04 | 1 |
| Amgen Inc. | $15.13 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (30)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $22.75 | 01/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105953786 | CMS |
| ABBVIE INC. | $9.14 | 01/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105953788 | CMS |
| ABBVIE INC. | $4.00 | 03/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105953790 | CMS |
| ABBVIE INC. | $56.66 | 04/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105953792 | CMS |
| ABBVIE INC. | $9.95 | 05/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105953794 | CMS |
| ABBVIE INC. | $24.94 | 06/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105953796 | CMS |
| ABBVIE INC. | $5.28 | 08/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105953798 | CMS |
| ABBVIE INC. | $6.16 | 08/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105953800 | CMS |
| ABBVIE INC. | $5.09 | 09/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105953802 | CMS |
| ABBVIE INC. | $7.43 | 10/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105953804 | CMS |
| ABBVIE INC. | $5.29 | 10/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105953806 | CMS |
| Amgen Inc. | $15.13 | 03/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117365511 | CMS |
| AstraZeneca Pharmaceuticals LP | $17.78 | 02/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105581102 | CMS |
| AstraZeneca Pharmaceuticals LP | $14.09 | 07/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104402605 | CMS |
| AstraZeneca Pharmaceuticals LP | $13.84 | 08/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105589448 | CMS |
| AstraZeneca Pharmaceuticals LP | $15.34 | 10/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104712383 | CMS |
| GlaxoSmithKline, LLC. | $19.25 | 03/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116326092 | CMS |
| Insulet Corporation | $17.04 | 04/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116794977 | CMS |
| Lilly USA, LLC | $20.67 | 02/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135166335 | CMS |
| Lilly USA, LLC | $57.19 | 04/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135154773 | CMS |
| Lilly USA, LLC | $1.16 | 06/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135151424 | CMS |
| Lilly USA, LLC | $20.70 | 06/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135165939 | CMS |
| Lilly USA, LLC | $12.34 | 07/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135166339 | CMS |
| Lilly USA, LLC | $27.64 | 08/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135166013 | CMS |
| Lilly USA, LLC | $19.46 | 09/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135166337 | CMS |
| Mylan Specialty L.P. | $17.09 | 03/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147329602 | CMS |
| Mylan Specialty L.P. | $23.90 | 04/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147380075 | CMS |
| Mylan Specialty L.P. | $25.54 | 07/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147284410 | CMS |
| Mylan Specialty L.P. | $26.04 | 08/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147299733 | CMS |
| Vanda Pharmaceuticals Inc. | $17.17 | 08/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133918055 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.